Innoprot is a biotechnology company dedicated to advancing cell-based assays and technologies that support drug discovery and development. Our core expertise lies in the design and development of in vitro cellular models for evaluating the efficacy of biologics, including recombinant proteins and therapeutic antibodies such as FSH, TSH, LH, GLP-1, and a wide spectrum of GPCR agonists and antagonists. These models are offered either as standalone products for seamless integration into validation workflows or as customized solutions through our contract research services.
Moreover, Innoprot specializes in the isolation and supply of primary cell cultures from both human and animal sources, as well as the generation of immortalized cell lines derived from these cultures. These cellular systems provide robust and versatile platforms for advanced applications, including the production of cell pellets and extracellular vesicles (EVs).